Source: Business Wire

Press Release: Ocera : Hyperammonemia - Global Clinical Trials Review, H2, 2017 - Research and Markets

DUBLIN--(BUSINESS WIRE)--The "Hyperammonemia Global Clinical Trials Review, H2, 2017" clinical trials has been added to Research and Markets' offering. The clinical trial report, Hyperammonemia Global Clinical Trials Review, H2, 2017' provides an overview of Hyperammonemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperammonemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the g

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Linda S. Grais's photo - President & CEO of Ocera

President & CEO

Linda S. Grais

CEO Approval Rating

74/100

Read more